# Comparing the Effect of Dexmedetomidine Versus Intravenous Lidocaine on Colonoscopy Candidates Under Sedation with Propofol-Fentanyl: A Clinical Trial

**Authors:** Fatemeh Moftakhar, Reza Akhondzadeh, Fatemeh Hosseininejad, Sarina Alizade Ahvazi

PMC · DOI: 10.5812/aapm-138929 · Anesthesiology and Pain Medicine · 2023-12-23

## TL;DR

This clinical trial compares dexmedetomidine and lidocaine as sedatives during colonoscopy to see which provides better pain control and sedation.

## Contribution

The study provides new evidence on the comparative effectiveness of dexmedetomidine versus lidocaine in colonoscopy sedation.

## Key findings

- Dexmedetomidine significantly reduced heart rate after sedation compared to lidocaine.
- Dexmedetomidine resulted in lower pain scores at the end of the procedure.
- Both drugs caused minimal hemodynamic changes, but dexmedetomidine provided better sedation and analgesia.

## Abstract

Colonoscopy is an invasive and short-term diagnostic-therapeutic method that is associated with significant pain, discomfort, and anxiety in patients. Thus, various sedation and analgesia methods are used to reduce these complications.

This study compared the effect of dexmedetomidine versus intravenous lidocaine on colonoscopy candidates under sedation with propofol-fentanyl.

This double-blind clinical trial was conducted on two groups of randomly divided patients (n = 60 each) referring to the colonoscopy unit of Imam Khomeini Hospital in Ahvaz, Iran. The first group was given 2% intravenous lidocaine with an initial dose of 1.5 mg/kg and a maintenance dose of 1 mg/kg/h, plus propofol 0.5 mg/kg and 1 µg/kg fentanyl. In contrast, the second group was given dexmedetomidine with an initial dose of 1 µg/kg and a maintenance dose of 0.5 µg/kg/h plus 0.5 mg/kg propofol and 1 µg/kg fentanyl. Hemodynamic changes, degree of sedation, and patients' pain were measured and recorded at certain intervals.

No significant differences were observed between the dexmedetomidine and lidocaine groups regarding gender, age, and weight (P > 0.05), and the two groups were homogeneous in this regard. The two groups were significantly different with respect to their heart rate after sedation (from 5 to 20 minutes) (P < 0.05), which was lower in the group receiving dexmedetomidine. In terms of mean arterial blood pressure, no significant difference was found between the dexmedetomidine and lidocaine groups (P > 0.05). With respect to the pain score at the end of the procedure, the two groups were significantly different (P < 0.05), with the group receiving dexmedetomidine obtaining a lower score.

Although the use of lidocaine and dexmedetomidine is associated with the least hemodynamic changes, dexmedetomidine can create more suitable and favorable conditions during and after colonoscopy by inducing a higher degree of sedation and more analgesia.

## Linked entities

- **Chemicals:** dexmedetomidine (PubChem CID 5311068), lidocaine (PubChem CID 3676), propofol (PubChem CID 4943), fentanyl (PubChem CID 3345)

## Full-text entities

- **Diseases:** pain (MESH:D010146), anxiety (MESH:D001007)
- **Chemicals:** Fentanyl (MESH:D005283), Lidocaine (MESH:D008012), Dexmedetomidine (MESH:D020927), Propofol (MESH:D015742)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12535661/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12535661/full.md

## References

22 references — full list in the complete paper: https://tomesphere.com/paper/PMC12535661/full.md

---
Source: https://tomesphere.com/paper/PMC12535661